No Data
Volume change rate ranking (9 o'clock) - Takase, Koyosha Corporation, etc. ranked in.
In the ranking of volume change rates, by comparing the average volume over the last 5 days with the volume on the day of distribution, it is possible to understand market participants' interests and trends in stock selection etc. ■Top volume change rates [As of December 4th, 9:32] (compared to the average volume over the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <9087> Takase 200142.92 400% 0% <7946> Koyo Co. 210084.98 357.11%
December 4th [Today's Investment Strategy]
[FISCO Selected Stocks] [Material Stocks] JCR Pharma <4552> 727 yen (12/3) Human growth hormone preparations are the main products. Regarding the blood-brain barrier crossing type α-N-acetylglucosaminidase preparation (JR-446) developed by the company, the first administration to the first subject targeted at mucopolysaccharidosis type 3B (MPS3B) in clinical phase 1/2 trials in Japan was announced. MPS3B is being jointly developed and commercialized with Medipal Holdings <7459>.
Pay attention to JCR Pharma and ABC Mart, while Uchida Yoko and Tsukishima HD may be sluggish.
In the U.S. stock market on the 3rd of yesterday, the dow jones industrial average decreased by 76.47 dollars, closing at 44,705.53, the nasdaq rose by 76.96 points to 19,480.91, and the Chicago Nikkei 225 futures increased by 90 yen compared to during the day in Osaka, reaching 39,240 yen. The exchange rate is 1 dollar = 149.50-150.00 yen. In today's Tokyo market, the same-store sales for November increased by 14.7%, expanding from the 6.3% growth in October for ABC Mart <2670>, and the same-store sales for November rose by 8.9%, compared to the 6.3% in October.
Japan Machinery Orders Decline 2.9% in September
Takakita: Semi-Annual Report - Term 81 (2024/04/01 - 2025/03/31)
Takakita: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)